Register Today for IQVIA’s Tuesday Webinar on Surrogate Endpoints in Oncology Clinical Trials
August 11, 2021
The IQVIA Institute for Human Data Science will host a webinar at 10:00 AM EDT on Tuesday, August 17th on surrogate endpoints used in oncology clinical trials. Panelists will discuss the perspectives of payers, providers, and how surrogate endpoints are impacting reimbursement decision-making.
“The adoption of new, surrogate endpoints in clinical research provides a means to balance the need for timely patient access to innovative medicines without delays caused by using long-term survival endpoints with the means to measure clinical value for adjuvant and neoadjuvant therapies and allowing for the comparison of trials across multiple dimensions.” Learn more here and register.
(Source: The IQVIA Institute for Human Data Science, 2021)